Apr 6, 2009
By:
Jim Hall, Terry Stone, Mark Mozeson
The days of pharma sales reps going office-to-office with samples and brochures are done. These days, they need to turn their attention to payers, pharmacists, and consumers
|
New drug coverage plans cost more money and serve fewer patients than the government expected. What if things get worse? Two scenarios for disaster.
May 1, 2006
By:
Wendy Huang, Jason Pesile, Mark Mozeson
As seniors become frustrated and Part D enrollment lags, drug benefit plans cannot grow fast enough to manage risk. Some leave the market, and others cut benefits.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
